Award
NIH Reporter #5K23HL163445-04
Targeting inflammation to improve rescue of CFTR by modulator therapy
Recipient
UNIVERSITY OF KANSAS MEDICAL CENTER
Award Amount
$171,995.00
Ceiling
$171,995.00
Awarded
March 30, 2026
Identifier
5K23HL163445-04
NIH grant awarded to UNIVERSITY OF KANSAS MEDICAL CENTER for research on CFTR modulators and inflammation in cystic fibrosis, focusing on losartan therapy, with a funding of about $172,000.
Description
This is a NIH grant opportunity for research on CFTR modulators and airway inflammation in cystic fibrosis, with a focus on evaluating losartan as a potential therapy. The project involves clinical trials, biomarker analysis, and in vitro studies. The award amount is approximately $172,000, with a project duration from May 2023 to March 2028.